Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Boehringer Ingelheim
Express Scripts
McKesson
Johnson and Johnson
Cipla
Mallinckrodt
Daiichi Sankyo

Generated: December 15, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for NIFEDIPINE

« Back to Dashboard

Payment Methods and Pharmacy Types for NIFEDIPINE (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $17,178,100
INSIDE ANOTHER STORE $22,728,929
[disabled in preview] $88,007,054
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 227,895
INSIDE ANOTHER STORE 671,583
[disabled in preview] 2,221,751
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $11,306,446
MEDICARE $50,751,900
[disabled in preview] $66,361,014
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for NIFEDIPINE
Drug Units Sold Trends for NIFEDIPINE

Annual Sales Revenues and Units Sold for NIFEDIPINE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2016
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2015
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2014
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2013
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2012
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2011
NIFEDIPINE ➤ Try a Free Trial ➤ Try a Free Trial 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Moodys
Dow
Accenture
Baxter
Healthtrust
Cerilliant
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.